دورية أكاديمية

P492: TAMIBAROTENE IN COMBINATION WITH VENETOCLAX AND AZACITIDINE IN PREVIOUSLY UNTREATED ADULT PATIENTS SELECTED FOR RARA-POSITIVE AML WHO ARE INELIGIBLE FOR STANDARD INDUCTION THERAPY (SELECT AML-1)

التفاصيل البيبلوغرافية
العنوان: P492: TAMIBAROTENE IN COMBINATION WITH VENETOCLAX AND AZACITIDINE IN PREVIOUSLY UNTREATED ADULT PATIENTS SELECTED FOR RARA-POSITIVE AML WHO ARE INELIGIBLE FOR STANDARD INDUCTION THERAPY (SELECT AML-1)
المؤلفون: Stein, E., de Botton, S., Pigneux, A., McMahon, C., Ball, B., Borthakur, G., Eghtedar, A., Kambhampati, S., Tache, J., Wang, E., Kelley, H., Volkert, A., Baker, K., Kang-Fortner, Q., Hodgson, G., Madigan, C., Warlick, E., Roth, D., Kelly, M., Pollyea, D.
المصدر: HemaSphere ; volume 6, page 391-392 ; ISSN 2572-9241
بيانات النشر: Wiley
سنة النشر: 2022
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1097/01.hs9.0000844856.73683.5f
DOI: 10.1097/01.HS9.0000844856.73683.5f
الإتاحة: https://doi.org/10.1097/01.hs9.0000844856.73683.5fTest
حقوق: http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.F5664F73
قاعدة البيانات: BASE